-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VjCN8W/Shiomb/sDfuGibWEJysbDG2ngcKMuZ8zA2tB3vyCexr4VT4JYg6qJZYW8 N7H50cNNxHgDBfuA1Eo6GA== 0000795551-09-000003.txt : 20090302 0000795551-09-000003.hdr.sgml : 20090302 20090302144037 ACCESSION NUMBER: 0000795551-09-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20090226 FILED AS OF DATE: 20090302 DATE AS OF CHANGE: 20090302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: THERAGENICS CORP CENTRAL INDEX KEY: 0000795551 STANDARD INDUSTRIAL CLASSIFICATION: INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS [3825] IRS NUMBER: 581528626 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5203 BRISTOL INDUSTRIAL WAY CITY: BUFORD STATE: GA ZIP: 30518 BUSINESS PHONE: 7702710233 MAIL ADDRESS: STREET 1: 5203 BRISTOL INDUSTRIAL WAY CITY: BUFORD STATE: GA ZIP: 30518 FORMER COMPANY: FORMER CONFORMED NAME: NUCLEAR MEDICINE INC DATE OF NAME CHANGE: 19860902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tarallo Francis J CENTRAL INDEX KEY: 0001332909 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14339 FILM NUMBER: 09646874 BUSINESS ADDRESS: BUSINESS PHONE: 770-271-0233 MAIL ADDRESS: STREET 1: 5203 BRISTOL INDUSTRIAL WAY CITY: BUFORD STATE: GA ZIP: 30518 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2009-02-26 0000795551 THERAGENICS CORP TGX 0001332909 Tarallo Francis J 5203 BRISTOL INDUSTRIAL WAY BUFORD GA 30518 0 1 0 0 Chief Financial Officer Theragenics Corporation common stock 2009-02-26 4 A 0 9150 A 75211 D Theragenics Corporation common stock 2009-02-26 4 A 0 18000 A 94388 D Stock Options (Right to Buy) .93 2009-02-26 4 A 0 40000 0 A 2019-02-26 common stock 40000 146200 D Represents the performance-based component of a performance restricted stock right. The filing person has previously reported 6,000 shares issuable under the time-based vesting componment of performance restricted stock rights ("performance rights"). The performance-based vesting component of the performance rights were not deemed beneficially owned under Section 16. Rights granted for no consideration. Restricted Stock Award vesting 25% annually, commencing on 2/26/10. Restricted stock grant for no consideration Aggregate shares include Common Stock owned through the Theragenics Employee 401(k) Savings Plan Option Award exercisable at 25% annually, commencing on 2/26/10. /s/ Lynn Rogers, attorney-in-fact 2009-03-02 EX-24 2 poa_ft.htm POWER OF ATTORNEY FOR MR. TARALLO. Power of Attorney for Frank Tarallo

POWER OF ATTORNEY

        Know all by these presents, that the undersigned hereby constitutes and appoints Lynn Rogers, Assistant Secretary of Theragenics Corporation® with full power of substitution, the undersigned’s true and lawful attorney-in-fact to:

     
  (1) prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16 or Section 13 of the Securities Exchange Act of 1934 or any rule or regulation of the SEC;
     
  (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5 and Schedules 13D and 13G complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and
     
  (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

        The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

        This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 or Schedules 13D and 13G with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

        IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 12th day of July 2005.

     
     
    /s/ Francis J. Tarallo
          (Signature)
     
Signed in the presence of:    
/s/ Ann Lane    
      (Witness)    
     
/s/ F. Jay Scott    
      (Witness)    
     
Sworn and subscribed before me
This 12th day of July, 2005.
   
/s/ Lisa A. Rassel    
     
      (Notary Public)    
     
Lisa A. Rassel
Notary Public, Georgia
Hall County
Commission Expries December 18, 2011
   
-----END PRIVACY-ENHANCED MESSAGE-----